A recent case study emphasizes the importance of comprehensive molecular testing for patients diagnosed with adenocarcinoma, specifically within the context of non-small cell lung...
Recent advancements in the treatment of HER2-mutated non-small cell lung cancer (NSCLC) underscore the importance of incorporating patient preferences into treatment decisions. With the...